Maximizing Weight Loss vs. Protecting the Heart: The Paradox of Modern Anti-Obesity Drugs
As global demand for anti-obesity medications surges, a fierce pharmaceutical race is underway to develop next-generation successors to blockbusters...
Search results for "obesity medication"
GLP-1 Weight-Loss Drugs: Potential Metabolic Instability Linked to Long-Term Use
A new study suggests that the long-term administration of GLP-1 receptor agonists—the class of anti-obesity medications surging in popularity...
Taking Wegovy or Mounjaro? Seek Immediate Medical Attention if ‘These Symptoms’ Appear
As anti-obesity medications for weight loss and blood sugar control gain popularity, monitoring and managing potential...
Can Wegovy and Mounjaro Reduce Cancer Risk?
Global obesity experts have proposed a large-scale, long-term follow-up study to verify whether the use of modern...
(Eng Sub) Losing Weight: If You Don’t Do These Two Things, You Will Definitely Fail
To lose weight, eat less and exercise? "I didn’t lose it that way" The 38kg weight-loss secret from a Seoul National...
High Efficacy and Increased Convenience: The Three Obesity Drugs Awaiting FDA Approval
Since the World Health Organization recommended the use of obesity medications for adults last December, the market is...
The Surprising Life-Saving Potential of Weight Loss Meds in Diabetic Foot Care
GLP-1 receptor agonists (such as Wegovy and Ozempic), currently dominating the headlines as weight loss medications,...
Taking ADHD Medication in Childhood Increases Risk of Obesity
A study has found that long-term use of attention deficit hyperactivity disorder medication in childhood increases the...
Do Wegovy and Mounjaro Count as Doping? WADA Monitors GLP-1 Drugs in Sports
GLP-1 (glucagon-like peptide-1) class medications, such as Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro, are...
"Cut Carbs and Exercised, Yet Blood Sugar Stays High?" Nighttime Habits May Be to Blame
Prediabetes is a critical window of metabolic dysfunction. Left unmanaged, it frequently progresses to full-blown type...